{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:50:52Z","timestamp":1794873052633,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012331","name":"Flanders Innovation &amp; Entrepreneurship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le SIDA et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur Le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.antiviral.2022.105477","type":"journal-article","created":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T13:47:09Z","timestamp":1669470429000},"page":"105477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A stable hepatitis D virus-producing cell line for host target and drug discovery"],"prefix":"10.1016","volume":"209","author":[{"given":"Charlotte","family":"Bach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lucifora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Delphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heydmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux J.","family":"Heuschkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaku","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Scheers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Durantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloi R.","family":"Verrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105477_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2016.10.006","article-title":"HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes","volume":"136","author":"Alfaiate","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105477_bib2","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1073\/pnas.87.14.5253","article-title":"Continuous expression and replication of the hepatitis delta virus genome in Hep G2 hepatoblastoma cells transfected with cloned viral DNA","volume":"87","author":"Chen","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2022.105477_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/v14010065","article-title":"Inhibitory effect of IL-1beta on HBV and HDV replication and HBs antigen-dependent modulation of its secretion by macrophages","volume":"14","author":"Delphin","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2022.105477_bib4","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1038\/s41467-020-16517-w","article-title":"A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor","volume":"11","author":"Eller","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105477_bib5","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jhep.2019.06.032","article-title":"Hepatitis B virus-induced modulation of liver macrophage function promotes hepatocyte infection","volume":"71","author":"Faure-Dupuy","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2022.105477_bib6","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2022.105477_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nsmb.1440","article-title":"Capped small RNAs and MOV10 in human hepatitis delta virus replication","volume":"15","author":"Haussecker","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2022.105477_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13205","article-title":"Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis","volume":"22","author":"Herrscher","year":"2020","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2022.105477_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061486","article-title":"Hepatitis B virus entry into cells","volume":"9","author":"Herrscher","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.antiviral.2022.105477_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v13081532","article-title":"Cell culture models for the study of hepatitis D virus entry and infection","volume":"13","author":"Heuschkel","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2022.105477_bib11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.28772","article-title":"First international external quality assessment for hepatitis delta virus RNA quantification in plasma","volume":"64","author":"Le Gal","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2022.105477_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78001-1","article-title":"Quantification and epigenetic evaluation of the residual pool of hepatitis B covalently closed circular DNA in long-term nucleoside analogue-treated patients","volume":"10","author":"Lebosse","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2022.105477_bib13","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41467-019-10211-2","article-title":"Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation","volume":"10","author":"Lempp","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105477_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104812","article-title":"Current knowledge on hepatitis delta virus replication","volume":"179","author":"Lucifora","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105477_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105477_bib16","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1128\/JVI.74.16.7375-7380.2000","article-title":"The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication","volume":"74","author":"Modahl","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105477_bib17","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2022.105477_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46493-1","article-title":"Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus","volume":"9","author":"Ni","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2022.105477_bib19","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1128\/JVI.78.15.8120-8134.2004","article-title":"By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber\/W editing and its own expression","volume":"78","author":"Sato","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105477_bib20","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2022.105477_bib21","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1128\/jvi.68.6.4063-4066.1994","article-title":"The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus","volume":"68","author":"Sureau","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105477_bib22","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.jhep.2016.02.013","article-title":"The hepatitis delta virus: replication and pathogenesis","volume":"64","author":"Sureau","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2022.105477_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/jcm9010222","article-title":"Targeting the host for new therapeutic perspectives in hepatitis D","volume":"9","author":"Turon-Lagot","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.antiviral.2022.105477_bib24","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2020-323888","article-title":"Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease","volume":"70","author":"Urban","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2022.105477_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2022.105477_bib26","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.celrep.2016.09.084","article-title":"Solute carrier NTCP regulates innate antiviral immune responses targeting hepatitis C virus infection of hepatocytes","volume":"17","author":"Verrier","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2022.105477_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105250","article-title":"Loss of hepatitis D virus infectivity upon farnesyl transferase inhibitor treatment associates with increasing RNA editing rates revealed by a new RT-ddPCR method","volume":"198","author":"Verrier","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105477_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/gutjnl-2018-317065","article-title":"Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets","volume":"69","author":"Verrier","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2022.105477_bib29","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.4049\/jimmunol.1201625","article-title":"Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes\/macrophages by interfering with JNK activation","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2022.105477_bib30","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.antiviral.2022.105477_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4049\/jimmunol.1502301","article-title":"Characterization of the inflammasome in human kupffer cells in response to synthetic agonists and pathogens","volume":"197","author":"Zannetti","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2022.105477_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2018.02.021","article-title":"Hepatitis D virus replication is sensed by MDA5 and induces IFN-beta\/lambda responses in hepatocytes","volume":"69","author":"Zhang","year":"2018","journal-title":"J. Hepatol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222002467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222002467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:35:59Z","timestamp":1759062959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":32,"alternative-id":["S0166354222002467"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105477","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A stable hepatitis D virus-producing cell line for host target and drug discovery","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105477"}}